Effect of blood glucose & glycated hemoglobin levels on the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease

Abstract

The connection to hyperglycaemia & intense intensifications of persistent obstructive pneumonic infection (COPD) are presently starting to arise. Expanded blood glucose is related with unfriendly clinical results among patients with significant ailments. Hyperglycemia might be related with expanded mortality, length of stay (LOS), & re-confirmations in COPD patients. This study was finished in 80 hospitalized patients with intense compounding of persistent obstructive aspiratory sickness in the Department of pneumonic medication between June 2021 to January 2022. The segment, clinical data, lab results, radiographic outcomes, & data on Length of stay (LOS), mortality & re-confirmation were gathered. Point of the review is to concentrate on the impact of blood glucose, HbA1c levels on the mean length of medical clinic stay in patients of AECOPD. Out of 80 COPD individuals, 61(76%) were male & 19(24%) were female. Majority belonged to 56-65 years (38.8%), followed by 66-75 years (28.8%). Of the total 80 COPD individuals, 100% of male patients (n=61) were smokers, 15% of females (n=3) were smokers. Duration of the hospital stay was more with higher RBS values of ≥200mg/dl (9.2 ± 3.5 days) when compared to RBS value of 171-200 mg/dl (7.6±2.3 days) which was more than the RBS group with values of 141-170 (7.2±1.9 days). Whereas for normal RBS values of ≤140 mg/dl mean duration of hospital stay was (5.12±0.82 days). The conclusion arrived from our study, Higher the RBS at the time of admission, longer the mean duration of stay in the hospital. At admission, RBS more than 170 mg/dl is detrimental in AECOPD patients. High HbA1C levels (>6%) were associated with a high risk of exacerbations.